CU6 9.43% $5.57 clarity pharmaceuticals ltd

And if I'm reading it correctly, they've been thinking...

  1. 2,645 Posts.
    lightbulb Created with Sketch. 2390
    And if I'm reading it correctly, they've been thinking 12% market share, but the safety profile, sensitivity and efficacy results to date suggest that the market penetration could be multiples of that share.

    So, 12% of $10Bn equals $1.2Bn times 3-5 is $3.6Bn to $6Bn; and
    say, 30% of $10Bn equals $3Bn times 3-5 is $9Bn to $15Bn

    IMHO, good prospects AND really nice progress.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.